CABA
CABA
NASDAQ · Biotechnology

Cabaletta Bio Inc

$2.72
+0.04 (+1.49%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 3 19%
Sell 0 0%
Price Target
Analyst Price Target +1,362.9% upside
Low Target $29.42
Average Target $39.79
High Target $58.63
Current Price $2.72
Current
$2.72
Target
$39.79
$29.42 $39.79 avg $58.63
Scenario Analysis
Bear Case
$29.42
981.6%
Low target
Base Case
$39.79
+1,362.9%
Avg target
Bull Case
$58.63
+2,055.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.78
-28.0% from high
52-Week Low
$0.99
+175.9% from low
Target vs 52W High
$39.79
+952.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%